share_log

蓝帆医疗(002382.SZ)子公司心启冠状动脉球囊扩张导管获得中国NMPA注册

Lanfan Medical (002382.SZ) subsidiary Xinqi coronary balloon dilatation catheter obtained NMPA registration in China

Zhitong Finance ·  May 8 08:55

Lanfan Medical (002382.SZ) announced that Shanghai Lanfan Boyuan Medical Technology, a subsidiary of the company's cardiovascular division...

Zhitong Finance App News, Lanfan Medical (002382.SZ) announced that the three medical device products “Heart Qi Coronary Balloon Dilation Catheter” (“Heart Kai”) developed and produced by Shanghai Lanfan Boyuan Medical Technology Co., Ltd., a subsidiary of the company's cardiovascular division, have been approved and registered by the National Drug Administration (NMPA).

According to reports, Xinqi has a diameter of 0.7 mm; the high-pressure resistant material design makes it easy to expand high-resistance lesions; the new delivery system and hydrophilic coating design make it easy to expand high-resistance lesions; the new delivery system and hydrophilic coating design make it easier to complete complex lesions clinically.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment